Načítá se...

Efficacy and safety of intravenous golimumab plus methotrexate in patients with rheumatoid arthritis aged < 65 years and those ≥ 65 years of age

Abstract Objective To evaluate the safety and efficacy of intravenous golimumab + methotrexate (MTX) in patients with active rheumatoid arthritis (RA) aged < 65 years and those ≥ 65 years who were enrolled in the GO-FURTHER study. Methods In the phase III, double-blind, randomized, placebo-contro...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: John Tesser, Shelly Kafka, Raphael J. DeHoratius, Stephen Xu, Elizabeth C. Hsia, Anthony Turkiewicz
Médium: Artigo
Jazyk:Inglês
Vydáno: BMC 2019-08-01
Edice:Arthritis Research & Therapy
Témata:
On-line přístup:http://link.springer.com/article/10.1186/s13075-019-1968-x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!